A 52-year-old woman with a 10-year history of rheumatoid arthritis presents with nephrotic syndrome (proteinuria 4.5 g/day, serum albumin 2.1 g/dL). Renal ultrasound shows normal-sized kidneys without obstruction. Which investigation is most appropriate to confirm the diagnosis of secondary amyloidosis?

Explanation

## Diagnosis of Secondary (AA) Amyloidosis in Rheumatoid Arthritis **Key Point:** Renal biopsy with Congo red staining and mass spectrometry is the gold standard for confirming secondary amyloidosis (AA amyloidosis) in the setting of chronic inflammatory disease. ### Clinical Context: Secondary Amyloidosis in RA Secondary amyloidosis (AA type) occurs in chronic inflammatory conditions: - Rheumatoid arthritis (most common systemic autoimmune cause) - Chronic infections (tuberculosis, osteomyelitis) - Chronic inflammatory bowel disease - Malignancy (Hodgkin lymphoma, renal cell carcinoma) In this case, 10 years of RA with nephrotic syndrome strongly suggests AA amyloidosis. ### Why Renal Biopsy with Congo Red Staining? | Feature | Significance | |---------|-------------| | **Congo red staining** | Binds amyloid fibrils; produces apple-green birefringence under polarized light | | **Polarized light microscopy** | Confirms amyloid deposition; pathognomonic finding | | **Mass spectrometry** | Identifies amyloid type (AA vs. AL vs. ATTR); critical for prognosis and treatment | | **Electron microscopy** | Visualizes characteristic 7–10 nm unbranched fibrils | **High-Yield:** In secondary amyloidosis, mass spectrometry is essential because: - Confirms **AA amyloidosis** (derived from serum amyloid A, an acute-phase reactant) - Distinguishes from AL amyloidosis (which would require different treatment) - Guides management: AA amyloidosis requires control of underlying inflammation; AL requires chemotherapy ### Diagnostic Algorithm for Nephrotic Syndrome with Chronic RA ```mermaid flowchart TD A[RA + Nephrotic syndrome]:::outcome --> B[Renal ultrasound]:::action B --> C{Normal kidneys?}:::decision C -->|Yes| D[Exclude obstruction/diabetic nephropathy]:::outcome D --> E[Renal biopsy indicated]:::action E --> F[Congo red staining]:::action F --> G{Apple-green birefringence?}:::decision G -->|Yes| H[Amyloidosis confirmed]:::outcome H --> I[Mass spectrometry for typing]:::action I --> J{AA or AL?}:::decision J -->|AA| K[Control inflammation: NSAIDs, biologics]:::action J -->|AL| L[Chemotherapy + stem cell transplant]:::action ``` **Clinical Pearl:** Nephrotic syndrome in a patient with long-standing RA should raise suspicion for amyloidosis. Unlike diabetic nephropathy (which shows nodular glomerulosclerosis), amyloidosis shows characteristic amyloid deposits on Congo red staining. **Mnemonic: AA amyloidosis risk factors — CHIT** - **C**hronic inflammation (RA, IBD) - **H**ealth conditions (TB, osteomyelitis) - **I**nflammatory bowel disease - **T**umors (Hodgkin, RCC) [cite:Robbins 10e Ch 6]